Gevorg Grigoryan, PhD, is co-founder and chief technology officer at Generate Biomedicines, where he oversees the company’s generative biology drug generation platform that enables the generation of new drugs on demand across a range of biologic modalities. Gevorg is a renowned researcher across multiple disciplines. In addition to his role at Generate, he is a research associate professor of computer science, biological sciences, and chemistry at Dartmouth College.
Gevorg’s research at Dartmouth focuses on understanding the relationship between amino-acid sequence and structure, seeking rigorous ways of inferring principles governing protein folding, interaction, and function from data. This work uncovered a fundamentally new paradigm for the design of macro-molecules that was the basis for his collaboration with Flagship Pioneering and the founding of Generate Biomedicines.
Gevorg holds bachelor’s degrees in computer science and biochemistry and earned his PhD from the Massachusetts Institute of Technology, where he studied computational protein design and modeling of protein interactions. After completing his postdoctoral work at the University of Pennsylvania in 2011, Gevorg was appointed to the faculty at Dartmouth, where he obtained tenure in 2017.
Gevorg has authored over 50 peer-reviewed manuscripts and presentations, including in Nature, Science, Proceedings of the National Academy of Sciences (PNAS), and other top journals and conferences. His work has received awards and recognition from the Alfred P. Sloan Foundation, the National Institutes of Health, the National Science Foundation, and the American Cancer Society.